The purpose of this study was to evaluate the safety and intraocular-lowering efficacy of
anecortave acetate depot when administered by anterior juxtascleral depot (AJD) for the
treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or
- Patients 18 years of age or older with open-angle glaucoma (with or without pigment
dispersion or pseudoexfoliation) or ocular hypertension.
- Other protocol-defined inclusion criteria may apply.
- Patients with any form of glaucoma other than open-angle.
- Other protocol-defined exclusion criteria may apply.